Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Diabetes Virus Detection and Intervention Trial (DiViDIntervention)

Next Previous
Trial Profile

The Diabetes Virus Detection and Intervention Trial (DiViDIntervention)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 18 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pleconaril (Primary) ; Ribavirin (Primary)
  • Indications Viral infections
  • Focus Pharmacodynamics
  • Acronyms DiViDIntervention

    • Most Recent Events

    • 18 Dec 2023 Sweden is the planned location as per European Clinical Trials Database record.
    • 01 Nov 2023 Results published in the Nature Medicine
    • 06 Oct 2023 Primary endpoint (The primary endpoint is change in mean residual insulin secretion measured by Mixed Meal Tolerance Test (MMTT) stimulated C-peptide two-hour area under the curve profile from visit 1 to 12 months after initiation of study treatment.) has been met according to results presented at the 59th Annual Meeting of the European Association for the Study of Diabetes.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top